MCDS
JPMorgan Fundamental Data Science Mid Core ETF
The JPMorgan Fundamental Data Science Mid Core ETF seeks to invest primarily in mid-cap equity securities that exhibit strong fundamental characteristics and are identified through a data science-driven investment process.
US
EQUITY
Active
MANAGEMENT STYLE
$ 9.3 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Aug 07, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| MARATHON PETROLEUM | 1.7 % |
| HEWLETT PACKARD ENTERPRISE CO. | 1.5 % |
| NATERA INC | 1.4 % |
| WABTEC CORP | 1.2 % |
| TERADYNE INC | 1.2 % |
| STATE STREET CORP | 1.2 % |
| CARDINAL HEALTH INC | 1.1 % |
| SNOWFLAKE, INC. CLASS A | 1.1 % |
| M & T BANK CORP | 1.0 % |
| AMETEK INC | 1.0 % |
Constituent Breakdown
| Number of holdings | 208 |
| Herfindahl-Hirschman Index | 8 |
| Wgt avg mkt cap (mns) | $35,770 |
| Large cap (>$10bn) | 26.6% |
| Mid cap ($2-10bn) | 2.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 28.7% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 91.7 % |
 |
IRELAND | 1.0 % |
 |
BRITAIN | 1.0 % |
 |
BERMUDA | 0.9 % |
 |
SWITZERLAND | 0.8 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 11.0% | 12.1% | 8.4% | -- | -- | -- | -- | 12.0% |
| Dividend Yield | 0.7% | 1.2% | 1.3% | -- | -- | -- | -- | 1.3% |
| Total Returns | 11.8% | 13.3% | 9.7% | -- | -- | -- | -- | 13.3% | Ann. Volatility | 13.3% | 13.2% | 16.5% | -- | -- | -- | -- | 16.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.83 | 66% |
| MSCI EAFE | 0.63 | 57% |
| MSCI Emg Mkts | 0.34 | 41% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 0.7% |
| Avg. Bid/Ask (% of price) | 0.06% |
Technical Indicators
| 30d moving avg. (EMA) | $68.25 |
| Relative strength (RSI) | 66 |
| MACD/Signal | 0.83/0.64 |
| Bollinger Bands (Upper/Lower) | $70.73/$66.00 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MCDS |
Expenses vs. MCDS |
ALTAR Score™ vs. MCDS |
|---|---|---|---|---|
| VO | Vanguard Mid-Cap ETF | 37.7% | -31 bp | +0.2% |
| IWR | iShares Russell Midcap ETF | 35.8% | -16 bp | +0.3% |
| IMCG | iShares Morningstar Mid-Cap Growth ETF | 33.2% | -29 bp | -1.9% |
| IMCB | iShares Morningstar Mid-Cap ETF | 32.1% | -31 bp | +0.1% |
| IWS | iShares Russell Mid-Cap Value ETF | 31.9% | -12 bp | +1.4% |
| FMDE | Fidelity Enhanced Mid Cap ETF | 31.3% | -12 bp | +0.1% |
| AVMC | Avantis U.S. Mid Cap Equity ETF | 30.5% | -17 bp | +0.6% |
| JHMM | John Hancock Multifactor Mid Cap ETF | 29.3% | +7 bp | +0.4% |
| VOE | Vanguard Mid-Cap Value ETF | 29.1% | -28 bp | +1.9% |
| TPLC | Timothy Plan Fund Timothy Plan US Large/Mid Cap Core Fund | 28.2% | +17 bp | -0.3% |
Risk and Returns: MCDS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 10/13/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.9%
ALTAR SCORE™
57th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,393 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.2%. MCDS's ALTAR Score™ is approximately 0.2 standard
deviations above the category average. This places MCDS in the 57th percentile
among funds in the category.
Sell-Side Consensus
$81.86
PRICE TARGET
+23.0%
UPSIDE